Breath Analysis in Lung Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Idiopathic Pulmonary Fibrosis
Related studies linked through entity extraction aliases.
The Predictive Ability of 4MGS in IPF
- Status
- COMPLETED
- Phase
- N/A
PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- N/A
Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- NA
3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF
- Status
- COMPLETED
- Phase
- PHASE1
RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Auto-titrating Oxygen in Chronic Respiratory Failure
- Status
- COMPLETED
- Phase
- NA
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis
- Status
- WITHDRAWN
- Phase
- N/A
Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
- Status
- UNKNOWN
- Phase
- N/A
Azithromycin in Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- NA
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
- Status
- WITHDRAWN
- Phase
- PHASE2
Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
- Status
- COMPLETED
- Phase
- PHASE2